Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Sales | 1,024,030 | 922,555 | 739,117 | 638,095 | 549,181 |
| Cost of Goods | 494,264 | 459,033 | 359,588 | 315,195 | 270,164 |
| Gross Profit | 529,766 | 463,522 | 379,529 | 322,900 | 279,017 |
| Operating Expenses | 357,574 | 327,372 | 252,184 | 207,764 | 171,146 |
| Operating Income | 172,456 | 136,183 | 127,933 | 115,331 | 108,035 |
| Interest Expense | 4,589 | 4,179 | 462 | 96 | 155 |
| Other Income | 2,320 | 2,839 | 3,279 | 3,237 | 3,223 |
| Pre-tax Income | 170,187 | 134,843 | 130,750 | 118,472 | 111,103 |
| Income Tax | 54,018 | 40,829 | 37,224 | 40,670 | 33,165 |
| Net Income Continuous | 116,169 | 94,014 | 93,678 | 78,254 | 78,332 |
| Net Income | $116,169 | $94,014 | $93,678 | $78,254 | $78,332 |
| EPS Basic Total Ops | 0.97 | 0.77 | 0.75 | 0.60 | 0.57 |
| EPS Basic Continuous Ops | 0.97 | 0.76 | 0.75 | 0.60 | 0.57 |
| EPS Diluted Total Ops | 0.94 | 0.73 | 0.71 | 0.58 | 0.55 |
| EPS Diluted Continuous Ops | 0.93 | 0.73 | 0.71 | 0.57 | 0.55 |
| EBITDA(a) | $220,440 | $177,141 | $157,749 | $139,700 | $126,462 |